CIGNA Enters Global Individual Health Market; Launches CIGNA Global Health Options
- CIGNA continues to deliver on its global growth strategy by launching an international health care plan for globally mobile individuals.
- CIGNA Global Health Options is a modular international individual health care plan that can be purchased completely online, with a full application and underwriting process, available at www.cignaglobal.com .
CIGNA (NYSE:CI), the global leader in serving expatriates and other globally mobile individuals, has launched an international health care plan for qualified individuals who seek access to high-quality health care facilities across international boundaries.
The individual consumer market is a new area of focus for CIGNA’s expatriate benefits operation. With CIGNA Global Health Options, individuals have access to high-quality medical care worldwide backed by CIGNA’s expertise and capabilities in serving the group employer market.
“CIGNA Global Health Options is an innovative international health care plan that suits individuals’ unique needs, and it also marks an important milestone in CIGNA’s growth strategy. As the leader in the globally mobile market, the launch of this innovative, modular product extends our reach to support the needs of new customer segments around the world,” said Andrew Kielty, president, CIGNA International Expatriate Benefits. “Our knowledge and strength in the group market, coupled with our expertise in direct marketing, presented a natural opportunity to offer the same access to quality health care to individuals we currently provide to organizations.”
The plan, which is available at www.cignaglobal.com , is designed for customers who want the flexibility of having easy access to quality health care around the world.
The “core” International Medical Insurance covers hospitalization, surgery, emergency care, cancer treatment, and maternity. All customers then have the flexibility to customize their overall solution by choosing from a range of four additional options:
- International Medical Insurance Plus (outpatient ): doctor visits, prescription drugs, and other outpatient treatments
- International Health and Well-being: routine exams, preventive screenings, and life management services
- International Vision and Dental : routine exams
- International Emergency Evacuation : transfer to the nearest world-class medical facility if required treatment is not available in the local country
CIGNA Global Health Options customers are served by a dedicated customer care team on hand 24/7 to authorize treatment, issue guarantees of payment, and answer all customer inquiries including claims, treatment plans, medical support and all other questions related to their health care plan.
For information, contact sales_team@cignaglobal.com .
About CIGNA
CIGNA (NYSE: CI) is a global health service and financial company dedicated to helping people improve their health, well-being and sense of security. CIGNA Corporation's operating subsidiaries in the United States provide an integrated suite of health services, such as medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance. Outside the U.S., CIGNA serves expatriates in virtually every country in the world and provides employers, affinity groups and individuals access to quality local and global health care and related financial protection programs. CIGNA offers products and services in over 27 countries and jurisdictions and has approximately 65 million customer relationships throughout the world. To learn more about CIGNA, visit www.cigna.com . To sign up for email alerts or RSS feed of company news, log on to http://newsroom.cigna.com/section_display.cfm?section_id=18
Contact:
CIGNA
Gloria Barone, 215-761-4758
Gloria.barone@cigna.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 202512.6.2025 12:00:00 CEST | Press release
Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filingsPhase 1 study of BCL2 inhibitor sonrotoclax plus BRUKINSA® elicited deep responses – 96% ORR in R/R CLL and 79% ORR in R/R MCL patients – with no new safety signals in the latest resultsBTK degrader BGB-16673 shows strong early results in hard-to-treat populations BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association (EHA) Congress. Four oral presentations highlight the promising clinical activity of BeOne’s next-generation BCL2 inhibitor sonrotoclax, BTK protein degrader BGB-16673, and the backbone of our hematology franchise, BTK inhibitor BRUKINSA (zanubrutinib), which has the broadest label globally of any approved BTK inhibitor. These data reinforce
Infobip Named Among Top 75 in Fortune’s Europe’s Most Innovative Companies 202512.6.2025 10:17:00 CEST | Press release
Fortune ranking aligns with Infobip’s innovative efforts in the IT industry and digital infrastructure Global communications platform Infobiphas been recognized among the top 75 companies in Fortune’s inaugural ranking of Europe’s Most Innovative Companies for 2025. It holds the position of number 68, placing it in the top 25% of all listed companies. This distinction reflects Infobip’s ongoing commitment to advancing Europe’s IT sector and digital infrastructure through cutting-edge innovation. The first Fortune Europe’s Most Innovative Companies list, created in collaboration with Statista, evaluated 300 companies from 21 countries and 16 industries based on innovation culture, product development, and process improvements. Infobip is at the forefront of Europe’s digital transformation. Infobip participates in the IPCEI-CIS project, which aims to build the next-generation global communications platform, thereby reinforcing Europe’s competitiveness in the tech sector. Infobip’s involv
Craig Cook appointed Chief Business Officer and Co-founder at ABILITY Neurotech, the Wyss Geneva’s flagship spin-off12.6.2025 09:00:00 CEST | Press release
The Wyss Center for Bio and Neuroengineering proudly announces the appointment of Craig Cook, former Head of Business Development & Licensing at the Center, as Chief Business Officer and Co-founder of ABILITY Neurotech SA, a pioneering spin-off company translating breakthrough brain-computer interface (BCI) technology into clinical impact. During his tenure at the Wyss Center, Craig Cook played a transformative role in establishing a strong business development framework and positioning the organization as a venture builder in neurotechnology. Under his leadership, six breakthrough technologies were successfully spun out into operational startup companies: Clee Medical SA, Brainscape Medical SA, Dataflight Ltd, BrainQuant SA, Aleos Bio SA, and ABILITY Neurotech SA. In parallel, Craig led the onboarding of aligned startups such as Dandelion Science Corp. and dEEGtal Insights SA, strengthening our AI and neurotech ecosystem. He also contributed to Series A investments in two Wyss-affilia
SmartStream Brings AI-Powered Data Management to the Insurance Sector12.6.2025 09:00:00 CEST | Press release
SmartStream, the financial Transaction Lifecycle Management (TLM®) and solutions provider, has announced the expansion of its AI-driven reconciliation and data management platform, SmartStream Air, into the insurance sector. This move aims to help insurers tackle fragmented data challenges, reduce operational costs, and strengthen compliance through robust audit trails. As the insurance industry struggles with limited digital maturity, it faces mounting pressure from increasing transaction volumes, persistent data quality issues, and the complex demands of evolving regulations such as IFRS 17 and DORA. In this environment, the need for advanced, rapidly deployable SaaS data management solutions has never been more urgent. Addressing these challenges requires a fundamental transformation in how insurers manage systems, streamline operations, and ensure data integrity across the enterprise. SmartStream Air leverages cutting-edge AI to reconcile and manage high volumes of data, for exampl
Westlake Epoxy Announces Strategic Collaboration With Alpha Recyclage Composites to Advance Composites Recycling12.6.2025 08:00:00 CEST | Press release
Westlake Corporation (NYSE: WLK) announced today that Westlake Epoxy will collaborate with Alpha Recyclage Composites to support them in scaling up the recycling capacity for carbon fiber composite materials. This collaboration will provide support to Westlake’s composite customers in their development of improved circular options for both production (scrap or off spec composite materials that otherwise become waste) and end-of-life waste. The recovery of the carbon fibers from composite materials for reuse in new or emerging applications aims to establish a more sustainable alternative to traditional disposal methods such as landfilling and incineration. Alpha Recyclage Composites, a family-owned company based in Toulouse and Castelsarrasin, France, specializes in recycling carbon-fibers-reinforced composites through a patented steam pyrolysis process. This innovative technology preserves the performance qualities of the carbon fibers used in composite materials recovered from applica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom